Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_assertion type Assertion NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_head.
- NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_assertion description "[Here, we used low-density arrays, quantitative PCR, and western blotting to determine how HER2 signaling inhibition with lapatinib or PI3K inhibitors affects the expression of genes involved in breast cancer metastatic spread and overall prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_provenance.
- NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_assertion evidence source_evidence_literature NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_provenance.
- NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_assertion SIO_000772 20126311 NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_provenance.
- NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_assertion wasDerivedFrom befree-2016 NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_provenance.
- NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_assertion wasGeneratedBy ECO_0000203 NP791238.RAn0BYLKfaxju6bW4O9ogtyUg74CqdpX2jMH7TLML2f-I130_provenance.